1. Home
  2. AMRC vs OGN Comparison

AMRC vs OGN Comparison

Compare AMRC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameresco Inc.

AMRC

Ameresco Inc.

HOLD

Current Price

$31.31

Market Cap

1.4B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRC
OGN
Founded
2000
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
AMRC
OGN
Price
$31.31
$13.29
Analyst Decision
Strong Buy
Hold
Analyst Count
8
5
Target Price
$37.88
$11.40
AVG Volume (30 Days)
442.4K
14.9M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
0.49
0.72
Revenue
$1,769,928,000.00
$6,216,000,000.00
Revenue This Year
$10.71
$0.45
Revenue Next Year
$9.07
$1.67
P/E Ratio
$59.71
$18.42
Revenue Growth
28.76
N/A
52 Week Low
$11.48
$5.69
52 Week High
$44.93
$13.39

Technical Indicators

Market Signals
Indicator
AMRC
OGN
Relative Strength Index (RSI) 69.52 78.82
Support Level $29.05 $6.31
Resistance Level $34.29 N/A
Average True Range (ATR) 1.32 0.53
MACD 0.55 0.46
Stochastic Oscillator 97.17 98.00

Price Performance

Historical Comparison
AMRC
OGN

About AMRC Ameresco Inc.

Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: